Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Potent depletion of 5HT from monkey whole blood by a new 5HT uptake inhibitor, paroxetine (FG 7051).

Petersen EN, Bechgaard E, Sortwell RJ, Wetterberg L.

Eur J Pharmacol. 1978 Nov 1;52(1):115-9.

PMID:
102515
2.

An early clinical phase II evaluation of paroxetine, a new potent and selective 5HT-uptake inhibitor in patients with depressive illness.

Børup C, Meidahl B, Petersen IM, Vangtorp A, le Fèvre Honoré P.

Pharmacopsychiatria. 1982 Nov;15(6):183-6.

PMID:
6218507
3.

Paroxetine: pharmacokinetics, tolerance and depletion of blood 5-HT in man.

Lund J, Lomholt B, Fabricius J, Christensen JA, Bechgaard E.

Acta Pharmacol Toxicol (Copenh). 1979 Apr;44(4):289-95.

PMID:
433623
4.
5.
6.

Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.

Abdelmalik N, Ruhé HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, Büller HR, Schene AH, Kamphuisen PW.

J Thromb Haemost. 2008 Dec;6(12):2168-74. doi: 10.1111/j.1538-7836.2008.03196.x. Epub 2008 Oct 18.

7.
8.

Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.

Figueras G, Pérez V, San Martino O, Alvarez E, Artigas F.

Biol Psychiatry. 1999 Aug 15;46(4):518-24.

PMID:
10459402
9.

Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.

Pietraszek MH, Buczko W.

Eur J Pharmacol. 1987 Jun 4;137(2-3):273-5.

PMID:
3609146
10.

Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

Langer SZ, Galzin AM, Poirier MF, Loo H, Sechter D, Zarifian E.

J Recept Res. 1987;7(1-4):499-521.

PMID:
3040983
13.

Serotonergic status in human blood.

Ortiz J, Artigas F, Gelpí E.

Life Sci. 1988;43(12):983-90.

PMID:
2459577
14.

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.

Skinner MH, Kuan HY, Pan A, Sathirakul K, Knadler MP, Gonzales CR, Yeo KP, Reddy S, Lim M, Ayan-Oshodi M, Wise SD.

Clin Pharmacol Ther. 2003 Mar;73(3):170-7.

PMID:
12621382
15.
16.

Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine.

Waldmeier PC, Graf T, Germer M, Feldtrauer JJ, Howald H.

Biol Psychiatry. 1993 Mar 1;33(5):373-9.

PMID:
8471696
17.

The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.

Tulloch IF, Johnson AM.

J Clin Psychiatry. 1992 Feb;53 Suppl:7-12. Review.

PMID:
1531829
18.

The hypothermic effect of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in Wistar Kyoto rats.

Kulakowski EC, Hurst JH, Miller T, Linnoila M, Lovenberg W.

Life Sci. 1984 Sep 17;35(12):1329-35.

PMID:
6237238
19.
20.

Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine.

Sawamura K, Suzuki Y, Someya T.

Eur J Clin Pharmacol. 2004 Oct;60(8):553-7. Epub 2004 Sep 3.

PMID:
15349705

Supplemental Content

Support Center